Consensus statement on management of steroid sensitive nephrotic syndrome.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009402:Nephrosis, Lipoid / Q000175:diagnosis / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage* / Q000009:adverse effects; D011507:Proteinuria / Q000175:diagnosis / Q000188:drug therapy; D012008:Recurrence; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D011239:Prednisolone